โ† All deals

Vertical Longevity Pharmaceuticals, Inc.

BiotechnologyBiotechnologyVaccineImmunotherapy
๐Ÿ“ Irvine, CA, United Statesโ€ข Founded 2024
StreetZero Signal 66
Be the first to signal interest

About Vertical Longevity Pharmaceuticals, Inc.

Vertical Longevity Pharmaceuticals, Inc. is a biotechnology company developing a vaccine targeting atherosclerosis and systemic aging. The company focuses on an immunotherapy for cardiovascular and aging-related disease. It is based in Irvine, California and was founded in 2024.

LATEST FUNDINGPrivate Placement
$110K
Announced 2026-09-28
TOTAL RAISED$110,000
๐Ÿ”’

Unlock the full deal profile

Create a free account to see investors, key highlights, news, company details and the AI analysis for Vertical Longevity Pharmaceuticals, Inc..

Free plan includes 3 full deal profiles every month.

Investors

Not disclosed in the source filing. Form D filings do not list investors โ€” StreetZero surfaces them from news where available.

Key highlights

  • Raised $110,000 via private placement in Irvine, CA.
  • Developing vaccine for atherosclerosis and systemic aging.
  • Campaign on Netcapital surpassed $10,000 milestone for cardiovascular immunotherapy.
  • Proceeds allocated to R&D labor, subcontracts with Wake Forest CTSI, and manufacturing co-development.

Source document & SEC filing

The source SEC filing and the cached document are available to members only. Sign in to view and download them.

Sign in to view the filing Create free account